Bridging The Chasm Between Ideation & Commercialization For Advanced Therapy Startups

By Julie Diamond

While the recent number of new biotech companies suggests an ease to market entry, there are many challenges and factors that need to be addressed during the Startup phase. For example, it is critical to work as efficiently as possible before the first formal financing round, or “Seed” round. There is also consideration for how to quickly delivering medicine to patients, keeping burn rate low, fundraising, and mapping out a long-term strategy. Here we explore options to get startups off the ground and provide a look at RoosterBio products and services to aid startups in the mesenchymal stem cell (MSC) or extracellular vesicle (EV) / exosome space.